This protocol is judged by an institutional evaluate board, an impartial team that assessments any clinical trials involving human beings. If a analyze requires a Program I drug, once the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) number in the FDA.Even though the protocol